1.
Assessing the Privacy Risks of Data Sharing in Genomics
by Heeney, C
Community genetics, 2011-01-01, Vol.14 (1), p.17-25
2.
Institutional Shaping of Interagency Working: Managing Tensions between Collaborative Working and Client Confidentiality
by 6, Perri
Journal of public administration research and theory, 2006-12-05, Vol.17 (3), p.405-434
3.
Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: Complete protection of rhesus monkeys from mucosal SHIV challenge
by Sholukh, Anton M
Vaccine, 2015, Vol.33 (17), p.2086-2095
4.
The effect of water temperature on orthostatic tolerance: a randomised crossover trial
by Parsons, Iain T
Clinical autonomic research, 2022-04-23, Vol.32 (2), p.131-141
5.
Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission
by WATKINS, Jennifer D
AIDS (London), 2013, Vol.27 (9), p.F13-F20
6.
EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
by Bart, Pierre-Alexandre
Vaccine, 2008, Vol.26 (25), p.3153-3161
7.
CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection
by Bogers, W.M.J.M
Vaccine, 2004, Vol.22 (23), p.2974-2984
8.
A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection
by BOGERS, Willy M. J. M
AIDS (London), 2004, Vol.18 (1), p.25-36
9.
Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates
by Verstrepen, Babs E
Vaccine, 2008, Vol.26 (26), p.3346-3351
10.
Decreased expression of IL-2 in central and effector CD4 memory cells during progression to AIDS in rhesus macaques
by KOOPMAN, Gerrit
AIDS (London), 2001, Vol.15 (18), p.2359-2369
11.
Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs
by CZUB, S
Acta neuropathologica, 2001, Vol.101 (2), p.85-91
12.
Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model
by Suh, You S
Vaccine, 2006, Vol.24 (11), p.1811-1820
13.
TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, randomised controlled trial
by Ware, Russell E Russell E
The Lancet (British edition), 2015-12-06, Vol.387 (10019), p.661-670
14.
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
by Ensoli, Barbara
Nature medicine, 1999-06, Vol.5 (6), p.643-650
15.
16.
A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection
by MOOIJ, P
AIDS (London), 1998, Vol.12 (5), p.F15-F22
17.
Programmed cell death in AIDS-related HIV and SIV infections
by GOUGEON, M.-L
AIDS research and human retroviruses, 1993, Vol.9 (6), p.553-563
18.
19.
Stimulation of both humoral and cellular immune responses to HIV-1 gp120 by interleukin-12 in Rhesus macaques
by van der Meide, Peter H
Vaccine, 2002, Vol.20 (17), p.2296-2302
20.
The relative resistance of HIV type 1-infected chimpanzees to AIDS correlates with the maintenance of follicular architecture and the absence of infiltration by CD8+ cytotoxic T ly...
by KOOPMAN, G
AIDS research and human retroviruses, 1999, Vol.15 (4), p.365-373
